Frigid temperatures this weekend prompt cold weather advisories

MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. 

Turn Up Your Support

This week, a vaccine candidate for the novel coronavirus 

hit a new milestone and entered the second phase of clinical trials

. But what does that mean in terms of how soon this vaccine — or others — might be ready for public use? 

This vaccine is far from the only trial under way, with researchers around the world racing to safely produce a product — or products — to protect against COVID-19 infection.

Join Kerri Miller on our weekly show focusing on the science of the novel coronavirus as she talks with two researchers about how the vaccine development process works and the speed of the science happening during a pandemic. We’ll also answer your questions.

To listen to the full conversation you can use the audio player above.

Subscribe to the MPR News with Kerri Miller podcast on: 

Shows

Big Books & Bold Ideas with Kerri Miller

Health

COVID-19

Host

Author

As part of our weekly look at the science of the novel coronavirus, we focus on vaccine development with experts on vaccines and immunology.

Researchers discuss vaccine development, continued efforts on novel coronavirus

A researcher at Protein Sciences works in a lab

Researchers discuss vaccine development, continued efforts on novel coronavirus

Go Deeper.

Like this?